Isoangustone A suppresses mesangial fibrosis and inflammation in human renal mesangial cells

Experimental Biology and Medicine

Volumn 236, Issue 4, 2011, Pages 435-444

  Li, Jing ^a   Lim, Soon Sung ^a   Lee, Eun Sook ^a   Gong, Ju Hyun ^a   Shin, Daekeun ^a   Kang, Il Jun ^a   Kang, Young Hee ^a  

^a Hallym University   (South Korea)

Author keywords

High glucose; Inflammation; Isoangustone a; Mesangial cells; Renal fibrosis

Indexed keywords

COLLAGEN; CONNECTIVE TISSUE GROWTH FACTOR; GELATINASE A; GLUCOSE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERCELLULAR ADHESION MOLECULE 1; INTERSTITIAL COLLAGENASE; ISOANGUSTONE A; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1; PLANT MEDICINAL PRODUCT; SMAD PROTEIN; TRANSCRIPTION FACTOR RELA; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG; ISOFLAVONE DERIVATIVE;

ARTICLE; COLLAGEN SYNTHESIS; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG ISOLATION; EXPOSURE; GENE EXPRESSION; GLYCYRRHIZA URALENSIS; HUMAN; HUMAN CELL; KIDNEY CELL CULTURE; KIDNEY FIBROSIS; KIDNEY HYPERTROPHY; MESANGIUM CELL; MESANGIUM FIBROSIS; NEPHRITIS; NEPHROSCLEROSIS; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; UPREGULATION; CHEMICALLY INDUCED DISORDER; DRUG EFFECT; FIBROSIS; INFLAMMATION; MESANGIUM; PATHOLOGY; PATHOPHYSIOLOGY;

GLYCYRRHIZA; GLYCYRRHIZA URALENSIS;

FIBROSIS; GLOMERULAR MESANGIUM; HUMANS; INFLAMMATION; ISOFLAVONES;

EID: 79958794161     PISSN: 15353702     EISSN: 15353699     Source Type: Journal    
DOI: 10.1258/ebm.2010.010325     Document Type: Article

References (33)

1. Ban CR, Twigg SM. Fibrosis in diabetes complications: pathogenic mechanisms and circulating and urinary markers. Vasc Health Risk Manag 2008;4:575-596
2. Catania JM, Chen G, Parrish AR. Role of matrix metalloproteinases in renal pathophysiologies. Am J Physiol Renal Physiol 2007;292:F905-11
3. Pozzi A, Voziyan PA, Hudson BG, Zent R. Regulation of matrix synthesis, remodeling and accumulation in glomerulosclerosis. Curr Pharm Des 2009;15:1318-1333
4. Thrailkill KM, Clay Bunn R, Fowlkes JL. Matrix metalloproteinases: their potential role in the pathogenesis of diabetic nephropathy. Endocrine 2009;35:1-10
5. Hohenadel D, van der Woude FJ. Gene expression in diabetic nephropathy. Curr Diab Rep 2004;4:462-469
6. Ruiz-Ortega M, Rodríguez-Vita J, Sanchez-Lopez E, Carvajal G, Egido J. TGF-b signaling in vascular fibrosis. Cardiovasc Res 2007;74:196-206
7. Kanwar YS, Wada J, Sun L, Xie P, Wallner EI, Chen S, Chugh S, Danesh FR. Diabetic nephropathy: mechanisms of renal disease progression. Exp Biol Med (Maywood) 2008;233:4-11
8. Pohlers D, Brenmoehl J, Lo õffler I, Múller CK, Leipner C, Schultze-Mosgau S, Stallmach A, Kinne RW, Wolf G. TGF-b and fibrosis in different organs- molecular pathway imprints. Biochim Biophys Acta 2009;1792:746-56
9. Liu Y. Renal fibrosis: new insights into the pathogenesis and therapeutics. Kidney Int 2006;69:213-217
10. Fornoni A, Ijaz A, Tejada T, Lenz O. Role of inflammation in diabetic nephropathy. Curr Diabetes Rev 2008;4:10-17
11. Wu CC, Chen JS, Lu KC, Chen CC, Lin SH, Chu P, Sytwu HK, Lin YF. Aberrant cytokines/chemokines production correlate with proteinuria in patients with overt diabetic nephropathy. Clin Chim Acta 2010;411:700-704
12. Chen L, Zhang J, Zhang Y, Wang Y, Wang B. Improvement of inflammatory responses associated with NF-kB pathway in kidneys from diabetic rats. Inflamm Res 2008;57:199-204
13. Shi Y, Du C, Zhang Y, Ren Y, Hao J, Zhao S, Yao F, Duan H. Suppressor of cytokine signaling-1 ameliorates expression of MCP-1 in diabetic nephropathy. Am J Nephrol 2010;31:380-388
14. Giunti S, Tesch GH, Pinach S, Burt DJ, Cooper ME, Cavallo-Perin P, Camussi G, Gruden G. Monocyte chemoattractant protein-1 has prosclerotic effects both in a mouse model of experimental diabetes and in vitro in human mesangial cells. Diabetologia 2008;51:198-207
15. Berl T. Review: renal protection by inhibition of the rennin- angiotensin-aldosterone system. J Renin Angiotensin Aldosterone Syst 2009;10:1-8
16. Li GS, Jiang WL, Yue XD, Qu GW, Tian JW, Wu J, Fu FH. Effect of astilbin on experimental diabetic nephropathy in vivo and in vitro. Planta Med 2009;75:1470-1475
17. Li J, Kang SW, Kim JL, Sung HY, Kwun IS, Kang YH. Isoliquiritigenin entails blockade of TGF-b1-SMAD signaling for retarding high glucose-induced mesangial matrix accumulation. J Agric Food Chem 2010;58:3205-3212
18. Li X, Cui X, Sun X, Li X, Zhu Q, Li W. Mangiferin prevents diabetic nephropathy progression in streptozotocin-induced diabetic rats. Phytother Res 2010;24:893-899
19. Yamabe N, Yokozawa T, Oya T, Kim M. Therapeutic potential of (2)-epigallocatechin 3-O-gallate on renal damage in diabetic nephropathy model rats. J Pharmacol Exp Ther 2006;319:228-236
20. Ding DF, You N, Wu XM, Xu JR, Hu AP, Ye XL, Zhu Q, Jiang XQ, Miao H, Liu C, Lu YB. Resveratrol attenuates renal hypertrophy in early-stage diabetes by activating AMPK. Am J Nephrol 2010;31:363-374
21. Choi YJ, Lim SS, Jung JY, Choi JS, Kim JK, Han SJ, Kang YH. Blockade of nitroxidative stress by roasted licorice extracts in high glucose-exposed endothelial cells. J Cardiovasc Pharmacol 2008;52:344-354
22. Hatano T, Shintani Y, Aga Y, Shiota S, Tsuchiya T, Yoshida T. Phenolic constituents of licorice. VIII. Structures of glicophenone and glicoisoflavanone, and effects of licorice phenolics on methicillin-resistant Staphylococcus aureus. Chem Pharm Bull 2000;48:1286-1292
23. Kang SW, Choi JS, Choi YJ, Bae JY, Li J, Kim DS, Kim JL, Shin SY, Lee YJ, Kwun IS, Kang YH. Licorice isoliquiritigenin dampens angiogenic activity via inhibition of MAPK-responsive signaling pathways leading to induction of matrix metalloproteinases. J Nutr Biochem 2010;21:55-65
24. Lee YS, Kim SH, Kim JK, Shin HK, Kang YH, Park JHY, Lim SS. Rapid identification and preparative isolation of antioxidant components in licorice. J Sep Sci 2010;33:664-671
25. Kang SW, Choi JS, Bae JY, Li J, Kim DS, Kim JL, Shin SY, You HJ, Park HS, Ji GE, Kang YH. Blockade of vascular angiogenesis by Aspergillus usamii var. shirousamii-transformed Angelicae Gigantis Radix and Zizyphus jujuba. Nutr Res Pract 2009;3:3-8
26. Choi JS, Choi YJ, Shin SY, Li J, Kang SW, Bae JY, Kim DS, Ji GE, Kang JS, Kang YH. Dietary flavonoids differentially reduce oxidized LDL-induced apoptosis in human endothelial cells: role of MAPK- and JAK/STATsignaling. J Nutr 2008;138:983-990
27. Yuan WJ, Jia FY, Meng JZ. Effects of genistein on secretion of extracellular matrix components and transforming growth factor beta in high-glucose-cultured rat mesangial cells. J Artif Organs 2009;12:242-246
28. Hatano T, Kusuda M, Inada K, Ogawa T, Shiota S, Tsuchiya T, Yoshida T. Effects of tannins and related polyphenols on methicillin-resistant Staphylococcus aureus. Phytochemistry 2005;66:2047-2055
29. Peairs A, Dai R, Gan L, Shimp S, Rylander MN, Li L, Reilly CM. Epigallocatechin-3-gallate (EGCG) attenuates inflammation in MRL/lpr mouse mesangial cells. Cell Mol Immunol 2010;7:123-132
30. Chang JW, Kim CS, Kim SB, Park SK, Park JS, Lee SK. Proinflammatory cytokine-induced NF-kB activation in human mesangial cells is mediated through intracellular calcium but not ROS: effects of silymarin. Nephron Exp Nephrol 2006;103:e156-e165
31. Chiang CK, Sheu ML, Hung KY, Wu KD, Liu SH. Honokiol, a small molecular weight natural product, alleviates experimental mesangial proliferative glomerulonephritis. Kidney Int 2006;70:682-689
32. Zhou G, Li C, Cai L. Advanced glycation end-products induce connective tissue growth factor-mediated renal fibrosis predominantly through transforming growth factor beta-independent pathway. Am J Pathol 2004;165:2033-2043
33. Wiggins JE, Patel SR, Shedden KA, Goyal M, Wharram BL, Martini S, Kretzler M, Wiggins RC. NFkB promotes inflammation, coagulation, and fibrosis in the aging glomerulus. J Am Soc Nephrol 2010; 21:587-597